Published in Medical Letter on the CDC and FDA, May 11th, 2008
"To characterize dosing requirements, aPTTs, factors affecting dosage, and clinical outcomes in patients administered argatroban after coronary artery bypass graft (CABG) surgery. Charts of 39 patients who underwent CABG surgery and were administered argatroban...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA